Exercise and Movement to Enhance Resiliency in Gynecologic Cancer Patients
This study is looking at how a personalized digital exercise program and virtual support group can help women with gynecologic cancer. The program, called "Move" by Sword Health, uses a mobile app with tailored exercises, wearable technology, and support from a physical therapist. You would also have access to a virtual peer support group and health coaching sessions led by a UCSF-certified health coach. The study aims to see how easy it is to recruit participants and how much they like the program. It will also look at changes in physical activity and quality of life. This study is for women aged 18 or older who have been newly diagnosed with gynecologic cancer and are currently receiving treatment at the University of California, San Francisco.
- Study design
- This study plans to enroll 60 participants in two stages. The first stage is a single-arm pilot, and the second stage is a pilot randomized study comparing the program to usual care.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Recruitment and enrollment rates are measured up to 20 days.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Exercise and Movement to Enhance Resiliency in Cancer Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Stephanie Cham, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Recruitment Rate (Stage 1)Up to 20 days
Feasibility of the intervention is defined as \>= 30% recruitment rate for participants in Stage 1.
- Recruitment Rate (Stage 2)Up to 20 days
Feasibility of the intervention is defined as \>= 30% recruitment rate for participants in Stage 2.
- Enrollment Rate (Stage 1)Up to 20 days
Feasibility of the intervention is defined as \> 30% enrollment rate for participants in Stage 1.
- Enrollment Rate (Stage 2)Up to 20 days
Feasibility of the intervention is defined as \> 30% enrollment rate for participants in Stage 2.
- Percentage of participants recommending the EMPOWER intervention (Stage 1 & 2, EMPOWER Participants only)1 day
Acceptability of the intervention will be measured by a physician designed questionnaire assessing the acceptability of the EMPOWER intervention. The questionnaire is an 8-item measure of which assesses participants perceived acceptability of the EMPOWER program. Each item response falls on a scale of 1 (Strongly disagree) to 5 (Strongly agree). The percentage of participants with a response of either agree or strongly agree will be reported.
- Percentage of participants adherence to the intervention (Stage 2, EMPOWER Participants only)Up to 16 weeks
Adherence to the intervention will be measured for each participant, from week 1 to study completion per data collected by wearable device and by CHC collection. The percentage of participants will be reported